scispace - formally typeset
Search or ask a question
Institution

Dhaka Medical College and Hospital

EducationDhaka, Bangladesh
About: Dhaka Medical College and Hospital is a education organization based out in Dhaka, Bangladesh. It is known for research contribution in the topics: Population & Pregnancy. The organization has 2017 authors who have published 2099 publications receiving 13662 citations. The organization is also known as: DMC & DMCH.


Papers
More filters
Journal ArticleDOI
TL;DR: It is found that more than 40% of persons worldwide have FGIDs, which affect quality of life and healthcare use, and similar trends and relative distributions were found in people who completed internet vs personal interviews.

763 citations

Journal ArticleDOI
TL;DR: The present research reports the development and validation of a universal inventory that equips health professions/medical educators with a diagnostic tool to measure the state of their school's learning and teaching climate.
Abstract: The General Medical Council has initiated major innovations in the undergraduate medical curriculum. These requirements are forcing a rapid rate of change in medical schools throughout the UK which parallels many developments in North America. There have also been several international and national mission statements which call for similar reforms in education in the health professions. While the improvement of the learning environment and 'climate' is a major goal of the changes, the very rate of change is itself stressful. The present research reports the development and validation of a universal inventory that equips health professions/medical educators with a diagnostic tool to measure the state of their school's learning and teaching climate.

591 citations

Journal ArticleDOI
28 Jun 2017-Cureus
TL;DR: It is found that antibiotic resistance is increasing at an alarming rate and evidence from the literature suggests that the knowledge regarding antibiotic resistance in the population is still scarce, so the need of educating patients and the public is essential to fight against the antimicrobial resistance battle.
Abstract: Antibiotics are the 'wonder drugs' to combat microbes. For decades, multiple varieties of antibiotics have not only been used for therapeutic purposes but practiced prophylactically across other industries such as agriculture and animal husbandry. Uncertainty has arisen, as microbes have become resistant to common antibiotics while the host remains unaware that antibiotic resistance has emerged. The aim of this review is to explore the origin, development, and the current state of antibiotic resistance, regulation, and challenges by examining available literature. We found that antibiotic resistance is increasing at an alarming rate. A growing list of infections i.e., pneumonia, tuberculosis, and gonorrhea are becoming harder and at times impossible to treat while antibiotics are becoming less effective. Antibiotic-resistant infections correlate with the level of antibiotic consumption. Non-judicial use of antibiotics is mostly responsible for making the microbes resistant. The antibiotic treatment repertoire for existing or emerging hard-to-treat multidrug-resistant bacterial infections is limited, resulting in high morbidity and mortality report. This review article reiterates the optimal use of antimicrobial medicines in human and animal health to reduce antibiotic resistance. Evidence from the literature suggests that the knowledge regarding antibiotic resistance in the population is still scarce. Therefore, the need of educating patients and the public is essential to fight against the antimicrobial resistance battle.

549 citations

Journal ArticleDOI
Stella G. Muthuri1, Sudhir Venkatesan1, Puja R. Myles1, Jo Leonardi-Bee1, Tarig Saleh Al Khuwaitir2, Adbullah Al Mamun3, Ashish P Anovadiya4, Eduardo Azziz-Baumgartner5, Clarisa Báez, Matteo Bassetti, Bojana Beović6, Barbara Bertisch7, Isabelle Bonmarin8, Robert Booy9, Víctor Hugo Borja-Aburto10, Heinz Burgmann11, Bin Cao12, Jordi Carratalà13, Justin T Denholm, Samuel R. Dominguez14, Péricles Almeida Delfino Duarte15, Gal Dubnov-Raz16, Marcela Echavarria, Sergio Fanella17, Zhancheng Gao18, Patrick Gérardin19, Maddalena Giannella20, Sophie Gubbels21, Jethro Herberg22, A. Iglesias, Peter Höger23, Xiaoyun Hu24, Quazi Tarikul Islam25, Mirela Foresti Jiménez26, Amr Kandeel, Gerben Keijzers27, Hossein Khalili28, Marian Knight29, Koichiro Kudo, Gabriela Kusznierz, Ilija Kuzman30, Arthur M C Kwan31, Idriss Lahlou Amine, Eduard Langenegger32, Kamran Bagheri Lankarani33, Yee-Sin Leo34, Rita Linko35, Pei Liu36, Faris Madanat37, Elga Mayo-Montero, Allison McGeer38, Ziad A. Memish39, Gökhan Metan40, Auksė Mickiene41, Dragan Mikić42, Kristin G.-I. Mohn43, Kristin G.-I. Mohn44, Ahmadreza Moradi45, Ahmadreza Moradi46, Pagbajabyn Nymadawa, Maria E. Oliva, Mehpare Ozkan, Dhruv Parekh47, Mical Paul48, Fernando P. Polack49, Barbara Rath50, Alejandro Rodríguez, Elena B. Sarrouf, Anna C. Seale23, Anna C. Seale51, Bunyamin Sertogullarindan52, Marilda M. Siqueira53, Joanna Skręt-Magierło54, Frank P. Stephan55, Ewa Talarek56, Julian W. Tang57, Julian W. Tang58, Kelvin K. W. To59, Antoni Torres13, Selda Hançerli Törün, Dat Tran38, Timothy M. Uyeki60, Annelies van Zwol61, Wendy Vaudry58, Tjasa Vidmar, Renata T. C. Yokota, Paul Zarogoulidis, Jonathan S. Nguyen-Van-Tam1 
University of Nottingham1, King Saud Medical City2, International Centre for Diarrhoeal Disease Research, Bangladesh3, Government Medical College, Thiruvananthapuram4, Centers for Disease Control and Prevention5, Ljubljana University Medical Centre6, Kantonsspital St. Gallen7, Institut de veille sanitaire8, Children's Hospital at Westmead9, Mexican Social Security Institute10, Medical University of Vienna11, Capital Medical University12, University of Barcelona13, University of Colorado Denver14, State University of West Paraná15, Sheba Medical Center16, University of Manitoba17, Peking University18, National Institutes of Health19, Hospital General Universitario Gregorio Marañón20, Statens Serum Institut21, Imperial College London22, Boston Children's Hospital23, Peking Union Medical College Hospital24, Dhaka Medical College and Hospital25, Universidade Federal de Ciências da Saúde de Porto Alegre26, Gold Coast Hospital27, Tehran University of Medical Sciences28, University of Oxford29, University of Zagreb30, Pamela Youde Nethersole Eastern Hospital31, Stellenbosch University32, Shiraz University of Medical Sciences33, Tan Tock Seng Hospital34, University of Helsinki35, China Medical University (PRC)36, King Hussein Cancer Center37, University of Toronto38, Alfaisal University39, Erciyes University40, Lithuanian University of Health Sciences41, Military Medical Academy42, University of Bergen43, Haukeland University Hospital44, Johns Hopkins University School of Medicine45, Shahid Beheshti University of Medical Sciences and Health Services46, University of Birmingham47, Rambam Health Care Campus48, Vanderbilt University49, Charité50, University of Bristol51, Yüzüncü Yıl University52, Oswaldo Cruz Foundation53, Rzeszów University54, University Hospital of Basel55, Medical University of Warsaw56, University of Alberta Hospital57, University of Alberta58, University of Hong Kong59, National Center for Immunization and Respiratory Diseases60, VU University Medical Center61
TL;DR: There was an increase in the mortality hazard rate with each day's delay in initiation of treatment up to day 5 as compared with treatment initiated within 2 days of symptom onset, and early treatment versus no treatment was also associated with a reduction in mortality risk.

527 citations

Journal ArticleDOI
08 Apr 2021-PLOS ONE
TL;DR: In this paper, the authors conducted a prospective cohort study to determine the incidence, association, and risk factors associated with development of the post-coronavirus disease (COVID-19) syndrome.
Abstract: BACKGROUND: Post-coronavirus disease (COVID-19) syndrome includes persistence of symptoms beyond viral clearance and fresh development of symptoms or exaggeration of chronic diseases within a month after initial clinical and virological cure of the disease with a viral etiology. We aimed to determine the incidence, association, and risk factors associated with development of the post-COVID-19 syndrome. METHODS: We conducted a prospective cohort study at Dhaka Medical College Hospital between June 01, 2020 and August 10, 2020. All the enrolled patients were followed up for a month after clinical improvement, which was defined according the World Health Organization and Bangladesh guidelines as normal body temperature for successive 3 days, significant improvement in respiratory symptoms (respiratory rate 93% without assisted oxygen inhalation. FINDINGS: Among the 400 recruited patients, 355 patients were analyzed. In total, 46% patients developed post-COVID-19 symptoms, with post-viral fatigue being the most prevalent symptom in 70% cases. The post-COVID-19 syndrome was associated with female gender (relative risk [RR]: 1.2, 95% confidence interval [CI]: 1.02-1.48, p = 0.03), those who required a prolonged time for clinical improvement (p<0.001), and those showing COVID-19 positivity after 14 days (RR: 1.09, 95% CI: 1.00-1.19, p<0.001) of initial positivity. Patients with severe COVID-19 at presentation developed post-COVID-19 syndrome (p = 0.02). Patients with fever (RR: 1.5, 95% CI: 1.05-2.27, p = 0.03), cough (RR: 1.36, 95% CI: 1.02-1.81, p = 0.04), respiratory distress (RR: 1.3, 95% CI: 1.4-1.56, p = 0.001), and lethargy (RR: 1.2, 95% CI: 1.06-1.35, p = 0.003) as the presenting features were associated with the development of the more susceptible to develop post COVID-19 syndrome than the others. Logistic regression analysis revealed female sex, respiratory distress, lethargy, and long duration of the disease as risk factors. CONCLUSION: Female sex, respiratory distress, lethargy, and long disease duration are critical risk factors for the development of post-COVID-19 syndrome.

261 citations


Authors

Showing all 2021 results

Network Information
Related Institutions (5)
Apollo Hospitals
3.8K papers, 33.4K citations

78% related

University of Dhaka
9.8K papers, 136.4K citations

77% related

Sher-I-Kashmir Institute of Medical Sciences
2.4K papers, 48.7K citations

75% related

B.P. Koirala Institute of Health Sciences
2K papers, 47K citations

74% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20231
202211
2021117
2020105
201953
201898